Galenica AG
GALE
株式のランク
#3269
Galenica AG stands as a leading healthcare services company, serving both the... Galenica AG stands as a leading healthcare services company, serving both the Swiss market and international clients. Its operations are organized into two principal divisions: "Products & Care" and "Logistics & IT." The "Products & Care" division oversees an extensive network of 520 pharmacies, comprising 368 directly owned outlets and 152 partner-affiliated pharmacies, operating under the recognized brand names of Amavita, Sun Store, and Coop Vitality. Beyond retail pharmacy services, this segment also provides medication for patients receiving home-based treatment. It is also responsible for the introduction and distribution of a diverse portfolio of consumer health, pharmaceutical, and parapharmaceutical products, in addition to offering vital marketing and sales support to its collaborators within the healthcare sector. The "Logistics & IT" division specializes in offering a suite of pre-wholesale services tailored for pharmaceutical and healthcare enterprises. These services encompass essential functions such as secure storage, efficient distribution, and comprehensive debt collection. Furthermore, this segment provides various logistics and information technology solutions, including a master data system specifically developed for the healthcare industry. It actively creates advanced management solutions relevant to the healthcare market and publishes technical information on pharmaceutical products in both printed and electronic formats, alongside delivering complete management tools for pharmacies. Founded in 1927, Galenica AG maintains its headquarters in Bern, Switzerland.
株価
$108.43
時価総額
$5.40B
変化（1日）
1.19%
変化（1年）
-3.89%
国
CH
取引 Galenica AG (GALE)
カテゴリー
Healthcare
Galenica AG（GALE）の収益
Oct 2026 時点の収益 TTM: 0
Galenica AG の最新の財務報告によると、現在の収益 (TTM) は 0 です。2026 年には 0 の収益があり、これは 2026 年の 0 と比較して 同等 です。収益とは、企業が商品やサービスの販売によって得る総所得です。利益とは異なり、費用は差し引かれません。
Galenica AG の収益履歴（2014 ～ 2026）
各年末の収益
| 年 | 収益 | 変化 |
|---|---|---|
| 2025 | $5.21B | 20.06% |
| 2024 | $4.34B | -2.55% |
| 2023 | $4.45B | 2.58% |
| 2022 | $4.34B | 3.23% |
| 2021 | $4.21B | 8.58% |
| 2020 | $3.87B | 13.34% |
| 2019 | $3.42B | 6.01% |
| 2018 | $3.22B | -0.11% |
| 2017 | $3.23B | 9.17% |
| 2016 | $2.96B | 1.37% |
| 2015 | $2.92B | 2.49% |
| 2014 | $2.85B | 0.00% |
同業他社の収益
| 企業 | 収益 | 収益の差 | 国 |
|---|---|---|---|
| $410.98B | - |
US
|
|
| - | - |
US
|
|
| $254.25B | - |
US
|
|
| - | - |
US
|
|
| $7.64B | - |
AU
|
